OSTEOFOS-35 TAB 4's

About

Osteofos-35, typically containing a bisphosphonate like alendronate or risedronate 35mg, is a widely prescribed medication for the treatment and prevention of osteoporosis. This class of drugs works by selectively targeting and inhibiting the bone-resorbing activity of osteoclasts. By attaching to the bone surface, the active ingredient prevents these cells from breaking down bone tissue, which in turn helps to maintain or increase bone mineral density. This therapeutic action is vital for strengthening bones and significantly lowering the risk of osteoporotic fractures, especially in vulnerable areas such as the spine and hip. The once-weekly administration schedule is designed to offer convenience and improve patient compliance, ensuring consistent management of bone health over time.

Uses

• Treatment of postmenopausal osteoporosis.
• Prevention of postmenopausal osteoporosis.
• Treatment of osteoporosis in men.
• Treatment of glucocorticoid-induced osteoporosis.

Directions For Use

Take one tablet orally once a week, on the same day each week, at least 30 minutes before the first food, drink (other than plain water), or other medication. Swallow whole with a full glass of plain water while sitting or standing upright.

Benefits

• Reduces the risk of hip and spine fractures.
• Increases bone mineral density.
• Convenient once-weekly dosing.
• Helps maintain bone strength.
• Effective for various forms of osteoporosis.
• Supports long-term bone health.

Side Effects

• Esophageal irritation.
• Heartburn.
• Abdominal discomfort.
• Nausea.
• Diarrhea.
• Constipation.
• Musculoskeletal pain.
• Headache.
• Dizziness.
• Rash.
• Jaw osteonecrosis (rare).
• Atypical femur fractures (rare).

Safety Measures

• Alcohol - Excessive alcohol consumption can negatively impact bone health and may exacerbate osteoporosis. It is advisable to moderate alcohol intake.
• Pregnancy - Generally contraindicated during pregnancy due to potential risks to the fetus. Consult a healthcare provider if pregnant or planning to conceive.
• Breastfeeding - The excretion of this medication into breast milk is unknown. Caution is advised, and a doctor should be consulted to weigh risks and benefits.
• Liver - No specific dose adjustment is typically needed for mild to moderate hepatic impairment. Use with caution in severe liver disease.
• Kidney - Contraindicated in patients with severe renal impairment (creatinine clearance < 35 mL/min). Dose adjustment may be necessary for moderate impairment.
• Lung - No specific precautions related to lung conditions are generally associated with this medication.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.